Is Slynd (drospirenone) birth control associated with weight gain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Slynd and Weight Gain

Slynd (drospirenone progestin-only pill) is not associated with clinically significant weight gain and may actually help prevent the fluid retention-related weight gain seen with other hormonal contraceptives due to its unique antimineralocorticoid properties.

Mechanism and Evidence

Drospirenone is fundamentally different from other progestins because it acts as an aldosterone antagonist, similar to natural progesterone 1, 2. This antimineralocorticoid activity prevents sodium and water retention, which distinguishes it from other synthetic progestins that lack this property 1, 2.

Clinical Trial Data

  • Combination drospirenone products (drospirenone with ethinyl estradiol) demonstrated slight decreases in body weight compared to other oral contraceptives over 6 months of use 2
  • The antimineralocorticoid effect leads to mild natriuresis (sodium excretion) that counteracts estrogen-induced fluid retention 1, 2
  • In contraception trials with drospirenone-containing products, weight gain (≥2.5%) was reported in only 2.5% of users 3

Progestin-Only Pills Generally

Quality evidence for progestin-only pills and weight gain is limited, but available data suggest no clear association with significant weight change 4. A Cochrane review found evidence of weight gain specifically with medroxyprogesterone acetate (Depo-Provera) injections, but not with progestin-only pills 4.

Comparison to Other Methods

  • Medroxyprogesterone acetate (DMPA/Depo-Provera): The only hormonal contraceptive with clear evidence of weight gain, particularly >3 kg/year in a subgroup of users 4, 5
  • Combined oral contraceptives: Placebo-controlled trials show no evidence of causal association with weight gain 6
  • Weight-neutral options: Copper IUDs, barrier methods, and surgical sterilization remain the most definitively weight-neutral choices 4, 7

Clinical Monitoring Recommendations

  • Baseline weight and BMI measurement is useful for monitoring over time, though not required for safe initiation 4
  • Normal weight fluctuations of approximately 3 kg occur over 6-24 months with most hormonal contraceptives, similar to age-related weight changes in the general population 5
  • Cyclic weight fluctuations of 0.2 kg (0.5 pounds) occur naturally during menstrual cycles and may be misattributed to contraceptive use 8

Key Clinical Pitfall

Women often discontinue effective contraception due to perceived weight gain that is not actually caused by the method 8, 6. Counseling should emphasize that Slynd's unique antimineralocorticoid properties may actually reduce fluid retention compared to other hormonal options 1, 2.

References

Research

Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2002

Research

Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.

Climacteric : the journal of the International Menopause Society, 2005

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Weight gain due to hormonal contraception: myth or truth?].

Gynakologisch-geburtshilfliche Rundschau, 2009

Research

Combination contraceptives: effects on weight.

The Cochrane database of systematic reviews, 2003

Guideline

Weight Gain Associated with Contraceptive Methods

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.